Bernard R. Chevalier, MD

Country France
Specialty Interventional Cardiologist
  1. Invited Case Presentation & Focus Review: TAVI in Bicuspid Valve
  2. Corevalve Evolute R: The New Very Promising Generation of Corevalve
  3. Clinical Data: What Do We Learn from Absorb II Trial?
  4. An Algorithm to Choose Between 1- vs. 2- Stents for LM and Non-LM Bifurcation Stenosis
  5. Last Update About Bioabsorbable Coating Eluting Stent
  6. CYP2C19 Genetic Profiling for Thienopyridine Management After Primary Percutaneous Coronary Intervention
  7. Against: A Bad Taste, There Is No Benefit in Reality!
  8. Valve in Valve: Things That You Need to Know
  9. MSCT Is Mandatory Before and Useful After TAVI
  10. TASTE Trial: No Benefits, Time to Rethink?
  11. How to Optimize PCI Outcomes in Daily Practice
  12. [Metallic DES: Is There Room for Further Progress?] For: Yes, We Can Make DES Better!
  13. Always Single Stent in Any IVUS Findings
  14. Current DES System Is Sufficient.: No, New Technology Is Still Evolving.
  15. TAVI for Aortic Regurgitation and Complex Valvular Heart Disease
  16. Complications of TAVI
  17. Bifurcation: One, Two or Dedicated Stents?
  18. Guideline of LMT/Bifurcation Treatment
  19. Invited Case Presentation & Focus Review: Bifurcation Intervention
  20. NOBORI Clinical Program
  21. NOBORI 1 Data Up-Date
  22. Lessons Learnt from the Recent PCI Clinical Trials on DES
  23. EXPORT: A Prospective, Randomized Trial of Thromboaspiration During Primary Angioplasty in Acute Myocardial Infarction
  24. Long Lesions, Multivessel and Diffuse Disease
  25. DES in Acute MI
  26. ZOMAXX I: A Prospective, Multicenter, Randomized Trial of Zotarolimus-Eluting and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease: 9-Month Clinical and Angiographic Results